Richard J. Rodgers - 19 Apr 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role
Interim CEO and President, Director
Signature
/s/ Emily J. Johns, by Power of Attorney
Issuer symbol
IRD
Transactions as of
19 Apr 2023
Net transactions value
$0
Form type
4
Filing time
21 Apr 2023, 20:20:24 UTC
Previous filing
12 Jan 2023
Next filing
13 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Award $0 +50,000 +57% $0.000000 138,246 19 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units, which vest on the one-year anniversary of the date of grant.